DIPNA PHARMACHEM LIMITED

Healthcare · Pharmaceuticals & Biotechnology

BSE: 543594
₹4.36
Sept. 30, 2026 · BSE · bse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #176 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

CompanyMarket cap (₹ Cr)PE (TTM)ROE1Y returnDiv. yieldQualityValuationMomentum
Sun Pharmaceutical Industries Limited 435,863 146.5 13.7% 11.0% — 72 8 30
Divi's Laboratories Limited 246,660 83.9 15.3% 62.7% 0.32% 70 4 51
Torrent Pharmaceuticals Limited 162,454 78.2 12.2% 34.6% 0.79% 56 0 31
Zydus Lifesciences Limited 115,910 33.3 17.3% 17.2% 0.09% 74 24 84
Cipla Limited 108,736 35.4 11.2% -11.0% 0.97% 73 29 62
Laurus Labs Limited 106,969 122.5 17.1% 127.1% — 78 24 53
Mankind Pharma Limited 103,406 47.4 11.7% 2.6% — 68 12 86
Dr. Reddy's Laboratories Limited 102,916 154.7 10.9% -0.9% — 62 33 71
DIPNA PHARMACHEM LIMITED (this stock) 11 — — -51.7% — 67 100 45

Quarterly Financials

Data unavailable (no consolidated filing on record for this company/period range).

The detailed income statement is standalone-only: the consolidated feed carries just revenue, PBT and net profit.

Annual Financials

Data unavailable (annual figures are only available from the NSE iXBRL feed's coverage period).

Revenue Mix

Data unavailable.

Cash Flow

Data unavailable (only available from the NSE iXBRL feed's coverage period).

Balance Sheet (consolidated)

Data unavailable (only available from the NSE/BSE annual filing feeds' coverage period).